Ekos Corp Report issue

For profit Phase 3 Phase 4
Founded: Bothell WA United States (1995)
Status: Acquired by BTG (2013) → now Boston Scientific Corporation (2018)

Organization Overview

First Clinical Trial
2010
NCT01166997
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

EKOS Corporation